for Thank joining you, all thank Jesse, the call. and you
our and FY quarter, representing system and fourth highlights provide am quarter our and both our strong pleased solid the beyond. milestone. XX% This shipment by driven our I focus previous revenue 'XX for number with record of performance Today, reflecting in with total year-over-year, fourth of than on XX% areas shipments the commercial highest a I quarter fiscal the XXXX, and company operational execution. will growing within from was growth more accomplishments
FY reflects into where represented markets, underpenetrated at where player patient can #X open beginning going the prior the we entering or over and of customers more quarter, the by closing to access the year we the time. new particularly of radiation the In of international therapy accelerate shipments Momentum FY and in is out our strategy markets opportunities we saw both from remains revenue than fiscal the emerging laid 'XX which XXXX #X to and period. for XX% nicely, become elevated,
We growth also which up pent-up America. demand making driven product, orders system, emerging XX% largely C headwinds year-over-year, versus from C the market China saw the by despite in received quarter by new APAC in Tomo ship our to approval campaign X% orders precision end driven was by remaining for year, customers. recently for to last our the ready Tomo planning treatment anticorruption and Latin products grew growth
saw order region America of X-system within quarter, a this growth the share in including win priority for replacement is Latin than us, In more in Mexico. a and XXX% competitive
believe I indicator for ratio record leading healthy revenue. strong Finally, metric book-to-bill with revenue pleased a QX the with represent shipments X.X%. even global to very where at was was continues We future our book-to-bill
growth. driven which which significantly of growth to and China, APAC, the demand the product within by quarter, XX% grew in largest XX% Product rest the revenue contributed year-over-year, prior the strong grew revenue year-over-year compared by product IMEA, XX% up our region, year-over-year. approximately year materially delivered to revenue
We have put from market to exchange. several market. quarter for the strong up is our share and to initiatives developed revenue FX, #X us, a year-over-year, excluding share and and market was the product region very Japan Japan grew becoming to The we continue by headwinds X% for player path in this #X remain help drive on in impact foreign mitigate of gain the XX%.
Americas U.S. second show customer by delays product FY impact optimistic year-over-year, revenue conditions in 'XX improve in with to expected, 'XX. the in starting show weakness Finally, We greatest FY the will down and we've year-over-year half XX% as continued QX had and we in growth are in region, believe the we driven installation. see that of got cautiously the market
unfavorable down in parts were spare and to Japan Service training slightly due revenues revenue. for and reduced FX the quarter primarily
see of as I emerging However, result where year-over-year recurring installed that like XX% strategy start markets of growth was to the X% grew up penetrating China base service we driving am encouraged year-over-year. our revenue revenue service contract by
received we Planning step on System the During which final was for [indiscernible] Treatment process Precision platform. China, approval final to C quarter, the our in our Tomo the
segment. to As ability the the fee of systems quarter, late total fourth and now sell customers in have we ship B to Type full
margin this record China. end of time in total of from with we site the all can approval, venture fee to at joint Tianjin now reminder, a for shipments in As final fully our our customer delivery
With I Type discuss briefly B fully QX on are which in margins area we margins Ali years. market approval and approximately impacted of nature adjusted QX from initiatives. financials, compete touch productivity of within behind transitory were an our several us, market, have X but over achieved wanted the margin represents were improvements which next that focus, we more that although believe continues this EBITDA in negatively to underlying masked we our in range will now to the potential $X margins, able billion the overall expansion the factors we be expected, to
approval perspective, the delayed margin. China System we later recognize timing could From full Precision in of when a of Treatment product the Planning
challenged that which exchange, and Japanese at have expect a impacted now base. clearance FY margin accelerate in on we deferred margins of Within was C million 'XX the by end of shipments were our the majority Tomo With foreign 'XX. of FY our shipping materially begun us, $X we to approximately starting QX behind in where system based first FY late and have business represents the This to installed of shipped 'XX QX customer readiness. performance large mostly service customers
In a QX, addition, $X.X caused supplier parts costs. in consumption quality isolated million increase an experienced issue we in that
and be We Once the the for issue, are QX the recover majority supplier over resolved and adjusted year. this improved the gross working versus margin of in and closely to same deferral our year. the have the margins fiscal expect prior with been supplier period quality these costs the would China
U.S. headwind Finally, market is us. a region a which for higher-margin to margin mix we was the in experienced market, weakness as
U.S. by the in QX X%, are temporary encouraged challenge of order the improvement. the gradual market and U.S., which As discussed, performance we believe this grew is a signs in suggesting
I has revenue care 'XX, what our superior FY through on radiation remain globally, innovation, incredibly FY in full expanding which conversion the patient proud service therapy radiotherapy a year customers. indicator revenue accomplished into 'XX. of centered to humbled around timing access for recovery our remain performance, and order as to contributed of advancing monitoring support team mission, by our be and is U.S. our Moving and for delivering leading Reflecting the slowing as in this performance we will to significantly
in share trends ability well remain positive in. to We the secular gain well markets the execute in on industry participate as our and confident based as we our
and I in encouraged our global by am the markets. strong While emerging revenue momentum the for international year, was flat
revenues year-over-year whereas fiscal XX% XX% APAC grew China Excluding the the of Americas for year-over-year. XX% rest region, XXXX. international grew revenue grew year-over-year,
the independent XX% regions commonwealth Our driven and of of Americas before, Middle impact India, other year-over-year. IMEA CIS region year-over-year, year-over-year, declining subregion the as by East, the higher X.X% grew to growth And notably or down the continued part XX% was I region, by countries. most large in approximately markets U.S., largely FX. like driven lag mentioned Japan
U.S. near-term systems the that believe catalyst upgrade a installed market advanced of equipment we age replacement intact the capital potential of challenges in Despite base remains radiotherapy of opportunities. for long-term with the providing the and cycles, U.S. budget the
expect FY of where We into full second see FY estimate gradual 'XX the the we U.S. to 'XX of in half recovery. more a improvement in
down year-over-year. for year. Moving service full revenue fiscal was X% on revenue to Overall the
revenue contract year-over-year. However, X.X% recurring grew
of plan. that [indiscernible] actions, for which impact As with performance agreement stages and our leverage will service like installed contract performance from our we improvements downtime calls, serviceability underlying These expansion consumption. of predictive customer that base, of business The investments prior huge on growth. a mentioned service revenue Airbus, help early margin data pricing long-term reduce believe demonstrates revenue and reduce improve recurring include both parts our solutions to system will the opportunity uptime analytics and we is and
partnership club, Finally, education deliver the physics CyberKnife the service Genolier TrueNorth for education Switzerland. in like in offerings, our like new like advanced global solution innovation Cybercom partnership we newly opened solutions and introduced centers with which we will offerings and our in System,
overall margin We increasing drive and operational customer top improvements expect improvement line these satisfaction. will areas and while
pillars growth X have As articulated we major of are in our past, the plan. strategic there
Our first driving growth through top radiotherapy innovation needs. and our biggest pillar solve customers' advanced is to line
year, Customer strong. our been technology. and innovation adoption we of product the introductions Accuray product had strengthened During differentiated that our further several has portfolio new
growth in System to of towards in rapidly shorter growing prostate, trends included demand. latest neuro the this increase Notably, We course long treatments data for driving clinical and over treatments in a term System X XX% like clinical backed X the CyberKnife by is lung sessions year-over-year areas orders. the believe CyberKnife
of other next-generation our and customers markets treated treatment strong precision stereotactic of its advance use be SBRT for with in branding will awareness for developed of report further System Additionally, high be and replacement the for versus platforms the A many Japan. the System strong drive the base R&D many specifically System Europe the patient key radiosurgery U.S., installed to CyberKnife the investment area on focus to System our CyberKnife like expansion and CyberKnife due capabilities of to and requesting CyberKnife capabilities.
Imaging, approximately at expands and also 'XX. be progress by Radixact we works driven in FY functionality orders ESTRO continues product XX% CENOS as exception that adaptive 'XX, our at motion full the and which management ClearRT our which and of breast introduced [indiscernible] online a planning CT represents Customer to real-time Synchrony platform, capabilities are in treatment strong introduction
at Beyond also last India, other serve penetrating we fall. where challenged, Helix Congress particularly market, Cancer where product high-potential patient introduced to markets radiotherapy Indian the intend to is the new our access Accuray we China
follow and have months. to announcing we first ship product are for Today, India will the our release obtained unit this press coming to in CE in that the Mark we clearance
set pillar plan to strategic which and business, margin our service multiyear expanding next recurring stream revenue is a a service represents our growing business, and Our we opportunity. strengthen out expansion
Our has currently base. decade gated for XX% last essentially been fiscal global by and is the growth our Service contract 'XX. revenue of installed represents largely service revenue flat of over revenue our growth
region and APAC installed and expansion of saw level expanding the satisfaction. We're healthy both the a we U.S. growth the an with 'XX, X our growth the taking X meaningful in longer-term FY regions, of In commercial by of Japan our global focused and EIMEA goal base driven in approach customer footprint of service with in regions. commercial highest investment, our in ensuring
positioned profitability and best installed competitive as in upgrading our improving we're third with our cycle base. and So, our as pillar. own margins sheet replacement Expanding well balance
Ali expansion and a and XXXX, leaving plan with cost efficiencies multiyear no margin out laid drive I In of to multifaceted stone goal unturned. the
fluctuations, have material the made improvement to foreign laid still that costs goals we show and good in believe and actions out macro a scale. as us exchange that of as our margins innings we early increase have foundation impact have we improve of progress to the inflation, navigate While with factors to logistics improvement strong we helped against and are
and enhance existing partnerships win rate. FY development to market product and in us strengthened with Research we faster, with new these C-RAD, also partnerships bring strategic 'XX, solutions Airbus Finally, best-in-class alliances Radformation, the and funnel like our service and sales ones Healthcare Limbus GE partnerships TrueNorth. created believe We with improve AI, our our and help our
demand a We a wanted take in FY key into and of with some of moment to favorable FY highlight have a FY put backlog strong 'XX I enter us XXXX XXXX. that milestones orders, more the in going a full position $XXX year at X book-to-bill product orders for exceeding From the goal ratio over of an X.X. years global which we of our year-over-year revenue grow saw perspective, annual by of XX% X.X, represents million potential.
completed analytics team the this for of extremely us we on year better efficiencies. side, milestone SAP new foundational system decisions our operational productivity to help I'm a operational full without expect continued major drive make benefits I disruption. the our first further and ERP negative and data as company. proud On was improved the to
from inventory $XX the This fall, total delivered for As a fiscal us a be mentioned capital a million I've into and flow net going and we of improvement, past on reduction FY key working 'XX. for QX will priority in remains reduction year. million part cash $X
has long system we bills at B our journey Tianjin, the I in into Tomo and venture and team to XX in shipment for been first China Type C executing entering us, have ramp how pleased up market finally, June manufacturing Hospital. cross-functional worked of site And to in completing C first Tomo customer with joint our of am Shandong a the the
key key execute we our well milestones I will FY U.S. believe challenging, to indicators. behind us, these plan XXXX. performance continue With strategic are growth and The positioned to monitor in remains we
in aimed replacement closely to program, timing China remaining any market at we we and can in believe market Additionally, recovery. the tailwind These FY exact the therefore, trajectory campaign remain watch we that predict stimulus guidance our which but for slowdown in to stronger a timing market factors China addition signals see of 'XX, timing could including installations difficult will anticorruption are opportunities. to demand wait to conditions, believe included potential due related U.S. these be the and of impact
summary, penetrated achieved We forged markets the our improve customer growth. key strategic in in that except new and marketplace I'm enhance for and partnerships proud the solutions And competitiveness. foundation our future of we wins
we While where gaining line share top margin years. early growth over we our end profitability the drive the in markets and coming year still the growth, we in strong transformation, with compete in to are
our turn who will cover over I Ali, now it to will financials.